FRESENIUS MEDICAL CARE AG Deferred Tax Expense Income Recognised In Profit Or Loss
FRESENIUS MEDICAL CARE AG (FMS) reported Deferred Tax Expense Income Recognised In Profit Or Loss of -EUR 27.21 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss · last filed 2026-02-24
| Period end | Deferred Tax Expense Income Recognised In Profit Or Loss 12 month |
|---|---|
| 2025-12-31 | -27.21M EUR 20-F · filed 2026-02-24 |
| 2024-12-31 | -72.67M EUR 20-F · filed 2026-02-24 |
| 2023-12-31 | -122.15M EUR 20-F · filed 2026-02-24 |
| 2022-12-31 | -41.47M EUR 20-F · filed 2025-02-25 |
| 2021-12-31 | 67.26M EUR 20-F · filed 2024-02-20 |
| 2020-12-31 | 111.11M EUR 20-F · filed 2023-02-22 |
| 2019-12-31 | 64.27M EUR 20-F · filed 2022-02-22 |
| 2018-12-31 | 89.17M EUR 20-F · filed 2021-02-23 |
| 2017-12-31 | -203.05M EUR 20-F · filed 2020-02-20 |
| 2016-12-31 | -10.91M EUR 20-F · filed 2019-02-20 |
| 2015-12-31 | -38.49M EUR 20-F · filed 2018-02-27 |